Journal
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume 25, Issue 1, Pages 41-47Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2012.01.008
Keywords
diffuse large B cell lymphoma; FDG-PET; double hit lymphoma; cell or origin
Categories
Ask authors/readers for more resources
Clinically this chapter will focus on 3 important issues critical in the management of diffuse large B cell lymphoma (DLBCL) in 2012: risk stratification, interim PET-CT scanning and the role of high dose therapy and ASCT in the rituximab era for patients with relapsed and primary refractory disease. (C) 2012 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available